VanEck Associates’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.88M Buy
18,919
+1,858
+11% +$310K ﹤0.01% 959
2026
Q1
$3.58M Buy
17,061
+10,941
+179% +$2.75M ﹤0.01% 884
2025
Q4
$1.74M Buy
6,120
+2,119
+53% +$663K ﹤0.01% 1010
2025
Q3
$1.24M Sell
4,001
-308
-7% -$96.5K ﹤0.01% 1054
2025
Q2
$1.35M Sell
4,309
-92
-2% -$26.6K ﹤0.01% 1009
2025
Q1
$1.16M Sell
4,401
-502
-10% -$136K ﹤0.01% 1026
2024
Q4
$1.28M Sell
4,903
-105
-2% -$26.4K ﹤0.01% 999
2024
Q3
$1.18M Sell
5,008
-1,585
-24% -$325K ﹤0.01% 978
2024
Q2
$1.33M Sell
6,593
-1,995
-23% -$360K ﹤0.01% 965
2024
Q1
$1.47M Buy
8,588
+4,870
+131% +$908K ﹤0.01% 933
2023
Q4
$807K Buy
3,718
+103
+3% +$17.7K ﹤0.01% 990
2023
Q3
$577K Buy
3,615
+413
+13% +$92.5K ﹤0.01% 1014
2023
Q2
$923K Sell
3,202
-549
-15% -$167K ﹤0.01% 886
2023
Q1
$1.2M Buy
3,751
+277
+8% +$82.1K ﹤0.01% 793
2022
Q4
$1.02M Buy
3,474
+1,041
+43% +$287K ﹤0.01% 800
2022
Q3
$558K Buy
2,433
+691
+40% +$173K ﹤0.01% 872
2022
Q2
$380K Sell
1,742
-11
-0.6% -$2.5K ﹤0.01% 955
2022
Q1
$467K Buy
1,753
+108
+7% +$26.5K ﹤0.01% 958
2021
Q4
$438K Buy
1,645
+279
+20% +$80.9K ﹤0.01% 975
2021
Q3
$388K Buy
1,366
+285
+26% +$81.3K ﹤0.01% 947
2021
Q2
$297K Buy
+1,081
New +$294K ﹤0.01% 963

Other funds holding PODD

VanEck Associates's PODD Position: Q2 2026 in Review

VanEck Associates increased its Insulet (PODD) stake by 11% in Q2 2026, buying an estimated $310K and bringing the position to 18,919 shares worth $2.88M. The position accounts for ﹤0.01% of the portfolio, ranked #959.

VanEck Associates first reported a position in PODD in Q2 2021 and has held it in 21 quarters since. The position peaked at $3.58M in Q1 2026. 720 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • VanEck Associates held 18,919 shares of Insulet worth $2.88M as of Q2 2026.
  • VanEck Associates bought 1,858 Insulet shares in Q2 2026, an estimated $310K.
  • Insulet made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #959 holding.
  • VanEck Associates first reported a position in Insulet in Q2 2021 and has held it in 21 quarters since.
  • VanEck Associates's Insulet position peaked at $3.58M in Q1 2026.
  • 720 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.